fresolimumab human monoclonal immunomodulator intended treatment idiopathic pulmonary fibrosis ipf focal segmental glomerulosclerosis kidney cancer melanoma binds inhibits isoforms protein transforming growth factor beta fresolimumab discovered cambridge antibody technology cat one pair candidate drugs identified treatment fatal condition scleroderma cat chose codevelop two drugs metelimumab fresolimumab genzyme early development around cat decided drop development metelimumab favour february sanofiaventis agreed buy genzyme june drug tested humans clinical trials ipf renal disease august genzyme applied begin phase clinical trial primary focal segmental comparing fresolimumab versus placebo july sanofiaventis continue list fresolimumab research development portfolio phase ii immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikifresolimumab